On Monday 14th December, OHE’s Deputy Director Paula Lorgelly will lead an OHE Lunchtime Seminar on the topic of: HTA decision makers as budget takers and budget makers.
The seminar will highlight that decision-making criteria employed by health technology assessment (HTA) agencies differs between countries. Specifically, while the National Institute for Health and Care Excellence (NICE), the Australian Pharmaceutical Benefits Advisory Committee (PBAC) and the New Zealand Pharmaceutical Management Agency (PHARMAC) may seem similar, in one respect – assessing affordability – they are very different.
Using a number of case studies, including sofosbuvir for Hepatitis C, the decisions and deliberations of each agency and its Health Ministry will be compared. Additionally, there will also be a discussion of the UK’s Cancer Drug Fund, which exceeded its budget by 50%.
The presentation will conclude with a discussion of possible economic theories that may underpin improvements in approaches to HTA at NICE, PBAC and PHARMAC in the future.
View the full seminar invite here.
The seminar will be held in the King George V, Marriott County Hall, Westminster Bridge Rd, London, SE1 7PB. A buffet lunch will be available from 12:00 noon. The seminar will start promptly at 12.30 pm and finish promptly at 2.00 pm.
Please contact Kerry Sheppard if you wish to attend. Kerry will provide confirmation once she has received your request.
Click here for news of Paula’s appointment at OHE.
Posted in Health Technology Assessment, NICE | Tagged Events